Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 20 tags : Biopharma save search
Theravance Biopharma to Report Third Quarter 2021 Financial Results November 3, 2021
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
TBPH | $9.69 -2.32% -2.37% 470K
|
Health Technology
|
| O: 0.64%
H: 2.53%
C: -0.13%
INVA | $14.46 0.42% 0.41% 500K
|
Health Technology
|
| O: 0.3%
H: 1.5%
C: 0.3%
biopharma financial results results
Kedrion Biopharma to commercialize RYPLAZIM® (plasminogen, human-tvmh) in U.S. to address unmet need in patients with ultra-rare condition: Plasminogen Deficiency Type 1
Published: 2021-10-20 (Crawled : 11:00) - prnewswire.com
LMNL | $8.5 0.12% 0.12% 0
|
Health Technology
|
| O: 1.04%
H: 2.56%
C: -2.05%
biopharma rare
RedHill Biopharma to Present at the BIO-Europe 2021 Conference
Published: 2021-10-20 (Crawled : 11:00) - prnewswire.com
RDHL | $0.35 -13.41% -15.49% 980K
|
Health Technology
|
| O: 0.0%
H: 10.53%
C: 5.81%
biopharma europe conference presentation
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.